As the Remarkable Healing Qualities of CBD—a Component of Marijuana—Are Documented, Anti-Pot Drug Warriors Respond With CBDisinformation
Photo Credit: Shutterstock.com/Bad Man Production
Stay up to date with the latest headlines via email.
SAM’s anti cannabis polemic essentially boils down to this:
- Specific components of the marijuana plant, including CBD, have medical value, but the marijuana plant itself does not have medical value.
- THC, marijuana’s psychoactive component, is a horrible, dangerous substance, and children should not be exposed to it under any circumstances.
- Marijuana-derived products are against federal law and are not adequately tested for safety and efficacy, unlike FDA-approved corporate pharmaceuticals.
- State governments should not legalize marijuana to facilitate access to CBD. Those who need CBD should wait patiently until the federal government decides what CBD-rich medicines we are allowed to consume.
True enough. CBD-rich products should be made from organically grown cannabis, lab-tested for potency, mold and pesticides, and labeled for content and dosage. Certain CBD-products meet these criteria; others do not. Measurable doses of high quality, CBD-rich oil extracts, initially introduced in California, are currently available in some medical marijuana states. But cannabis products, including CBD-rich varieties, can’t be tested by “FDA-registered labs” because of the prohibitionist policies that SAM supports. Marijuana’s illicit status makes it impossible for analytical labs to handle such products with the FDA’s blessing.
In the world according to SAM, a product can’t be a medicine unless the FDA approves it as safe and effective. The FDA, however, is not in the business of approving plants as medicines. And the FDA approval process ensures neither safety nor efficacy. There are numerous examples of the FDA approving lethal Big Pharma meds that cure no better than a placebo. Pharmaceutical companies routinely hide clinical trial data about adverse side effects, falsify studies to win approval, and then rely on bribery, fraud, and deception to market dangerous drugs to unsuspecting patients, including children – all with a wink and a nod from the FDA, which treats corporate criminals like royalty. Big Pharma pays the FDA to fast-track cursory reviews, and the FDA enables widespread corruption within the pharmaceutical industry by routinely accepting drug company claims at face value while ignoring pertinent safety data. FDA scientists and whistleblowers risk retaliation by FDA management when they challenge Big Pharma prerogatives.